Insulet Corp. | Mutual Funds
Mutual Funds that own Insulet Corp.
American Funds Small Cap World Fund
3,696,897
6.27%
-73,703
1.02%
06/30/2018
PRIMECAP Odyssey Growth Fund
2,614,521
4.43%
0
2.02%
06/30/2018
Fidelity Growth Company Fund
1,965,757
3.33%
-10,666
0.42%
07/31/2018
PRIMECAP Odyssey Aggressive Growth Fund
1,964,956
3.33%
0
1.82%
06/30/2018
Vanguard Explorer Fund
1,653,167
2.8%
32,010
1.03%
06/30/2018
Vanguard Small Cap Index Fund
1,478,454
2.5%
19,651
0.16%
07/31/2018
Vanguard Total Stock Market Index Fund
1,476,885
2.5%
1,518
0.02%
07/31/2018
Fidelity Select Health Care Portfolio
1,097,014
1.86%
0
1.51%
07/31/2018
Fidelity Select Medical Equipment & Systems Portfolio
1,083,500
1.84%
0
2.02%
07/31/2018
ClearBridge Small Cap Growth Fund
1,007,853
1.71%
0
2.88%
01/31/2018
| Address |
100 Nagog Park
Acton Massachusetts 01720
United States
|
|
Employees
|
- |
| Website |
http://www.myomnipod.com |
| Updated |
07/08/2019 |
| Insulet Corp. is an innovative medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. |
